Lamisil Once

Terbinafine, the active ingredient in Lamisil Once, is a allylamine antifungal presented as a 1% cream for topical use. It treats fungal skin infections such as athlete's foot, ringworm and jock itch in adults and children.

GNH USA supplies Lamisil Once as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Terbinafine is an allylamine antifungal used to treat superficial dermatophyte infections.

- Tinea pedis: alleviates itching and clears fungal infection of the feet. - Tinea corporis: resolves ring-shaped skin lesions caused by dermatophytes. - Tinea cruris: treats fungal infection of the groin area, reducing redness and scaling.

Topical terbinafine may cause local skin reactions and, rarely, systemic adverse events.

Common Side Effects: - Burning sensation: mild burning at the application site. - Itching: localized itching or pruritus. - Redness: erythema of the treated skin. - Dryness: skin dryness or flaking.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or hives indicating hypersensitivity. - Contact dermatitis: severe irritation or eczema at the site. - Hepatotoxicity: rare liver enzyme elevations. - Stevens-Johnson syndrome: extremely rare severe skin reaction.

When using Lamisil Once, consider the following precautions.

- Apply only to intact skin: avoid broken or inflamed areas. - Avoid ocular or mucosal contact: wash hands after use. - Do not use with other topical antifungals unless directed: risk of irritation. - Discontinue if severe irritation or allergic reaction occurs: seek medical advice. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Terbinafine cream has limited systemic interactions, but certain combinations should be considered.

Major Interactions (Avoid): - Concurrent oral terbinafine: risk of systemic toxicity. - Occlusive dressings: increase absorption leading to systemic side effects.

Moderate Interactions (Monitor Closely): - Other topical antifungals: potential for local irritation. - CYP2D6 inhibitors (e.g., fluoxetine): may affect systemic metabolism if absorbed. - Alcohol: may increase liver strain in rare systemic exposure.